324 related articles for article (PubMed ID: 20188744)
1. Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression.
Pierpaoli E; Viola V; Pilolli F; Piroddi M; Galli F; Provinciali M
Life Sci; 2010 Apr; 86(17-18):668-75. PubMed ID: 20188744
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial-dependent anticancer activity of δ-tocotrienol and its synthetic derivatives in HER-2/neu overexpressing breast adenocarcinoma cells.
Viola V; Ciffolilli S; Legnaioli S; Piroddi M; Betti M; Mazzini F; Pierpaoli E; Provinciali M; Galli F
Biofactors; 2013; 39(4):485-93. PubMed ID: 23361894
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols.
Yu W; Simmons-Menchaca M; Gapor A; Sanders BG; Kline K
Nutr Cancer; 1999; 33(1):26-32. PubMed ID: 10227040
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo.
Weber T; Lu M; Andera L; Lahm H; Gellert N; Fariss MW; Korinek V; Sattler W; Ucker DS; Terman A; Schröder A; Erl W; Brunk UT; Coffey RJ; Weber C; Neuzil J
Clin Cancer Res; 2002 Mar; 8(3):863-9. PubMed ID: 11895920
[TBL] [Abstract][Full Text] [Related]
5. A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression.
Wang XF; Birringer M; Dong LF; Veprek P; Low P; Swettenham E; Stantic M; Yuan LH; Zobalova R; Wu K; Ledvina M; Ralph SJ; Neuzil J
Cancer Res; 2007 Apr; 67(7):3337-44. PubMed ID: 17409443
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway.
Wang XF; Witting PK; Salvatore BA; Neuzil J
Biochem Biophys Res Commun; 2005 Jan; 326(2):282-9. PubMed ID: 15582575
[TBL] [Abstract][Full Text] [Related]
7. Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
Provinciali M; Papalini F; Orlando F; Pierpaoli S; Donnini A; Morazzoni P; Riva A; Smorlesi A
Cancer Res; 2007 Mar; 67(5):2022-9. PubMed ID: 17332330
[TBL] [Abstract][Full Text] [Related]
8. Specific accumulation of gamma- and delta-tocotrienols in tumor and their antitumor effect in vivo.
Hiura Y; Tachibana H; Arakawa R; Aoyama N; Okabe M; Sakai M; Yamada K
J Nutr Biochem; 2009 Aug; 20(8):607-13. PubMed ID: 18824342
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms.
Yu W; Jia L; Wang P; Lawson KA; Simmons-Menchaca M; Park SK; Sun L; Sanders BG; Kline K
Mol Nutr Food Res; 2008 Apr; 52(4):447-56. PubMed ID: 18381678
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of breast cancer cell lines with a dual inhibitor of EGFR-HER-2/neu and a Bcl-2 inhibitor.
Witters LM; Witkoski A; Planas-Silva MD; Berger M; Viallet J; Lipton A
Oncol Rep; 2007 Feb; 17(2):465-9. PubMed ID: 17203189
[TBL] [Abstract][Full Text] [Related]
11. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
Pegram MD; Finn RS; Arzoo K; Beryt M; Pietras RJ; Slamon DJ
Oncogene; 1997 Jul; 15(5):537-47. PubMed ID: 9247307
[TBL] [Abstract][Full Text] [Related]
12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
[TBL] [Abstract][Full Text] [Related]
14. Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status.
Brodowicz T; Kandioler D; Tomek S; Ludwig C; Rudas M; Kunstfeld R; Koestler W; Hejna M; Budinsky A; Wiltschke C; Zielinski CC
Br J Cancer; 2001 Nov; 85(11):1764-70. PubMed ID: 11742500
[TBL] [Abstract][Full Text] [Related]
15. Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice.
Pierpaoli E; Viola V; Barucca A; Orlando F; Galli F; Provinciali M
Carcinogenesis; 2013 Jun; 34(6):1352-60. PubMed ID: 23430951
[TBL] [Abstract][Full Text] [Related]
16. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.
Hahn T; Szabo L; Gold M; Ramanathapuram L; Hurley LH; Akporiaye ET
Cancer Res; 2006 Oct; 66(19):9374-8. PubMed ID: 17018590
[TBL] [Abstract][Full Text] [Related]
17. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
[TBL] [Abstract][Full Text] [Related]
18. Alteration of α-tocopherol-associated protein (TAP) expression in human breast epithelial cells during breast cancer development.
Tam KW; Ho CT; Lee WJ; Tu SH; Huang CS; Chen CS; Lee CH; Wu CH; Ho YS
Food Chem; 2013 Jun; 138(2-3):1015-21. PubMed ID: 23411208
[TBL] [Abstract][Full Text] [Related]
19. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
20. Alpha-tocopheryl succinate selectively induces apoptosis in neuroblastoma cells: potential therapy of malignancies of the nervous system?
Swettenham E; Witting PK; Salvatore BA; Neuzil J
J Neurochem; 2005 Sep; 94(5):1448-56. PubMed ID: 16001965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
